A detailed history of Ruedi Wealth Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ruedi Wealth Management, Inc. holds 1 shares of REGN stock, worth $824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 2 50.0%
Holding current value
$824
Previous $2.1 Million 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$1024.09 - $1201.76 $1,024 - $1,201
-1 Reduced 50.0%
1 $1.05 Million
Q2 2024

Jul 17, 2024

BUY
$883.2 - $1071.19 $1,766 - $2,142
2 New
2 $2.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ruedi Wealth Management, Inc. Portfolio

Follow Ruedi Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruedi Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ruedi Wealth Management, Inc. with notifications on news.